iTransition Development

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Human Immunodeficiency VirusHIV Seropositivity
Interventions
BEHAVIORAL

iTransition

Is a mobile website application (app), and it can be used on a range of devices (computer, tablet, smartphone) and operating systems (iOS, Android, Windows). Features of iTransition will include, but are not limited to: medication reminders, calendar tracking of appointments, direct messaging between youth and providers, and privacy password lock.

Trial Locations (3)

19104

Children's Hospital of Philadelphia, Philadelphia

University of Pennsylvania Health System - HUP and Presby infectious disease clinics, Philadelphia

30303

Grady Hospital, Atlanta

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Emory University

OTHER

NCT04383223 - iTransition Development | Biotech Hunter | Biotech Hunter